Comparison of nine methods of immediate breast reconstruction after resection of localized breast cancer: A cost-effectiveness Markov decision analysis of prospective studies.

Microsurgery 2022 Vol.42(5) p. 401-427

Klifto KM, Tecce MG, Serletti JM, Kovach SJ

관련 도메인

Abstract

[BACKGROUND] Women undergoing immediate breast reconstruction without radiation therapy have reconstruction methods available with uncertain long-term costs associated with complications requiring surgery and revisions. We evaluated cost-effectiveness of nine methods of immediate breast reconstruction for women with localized breast cancer.

[METHODS] Markov modeling was performed over 10-years for unilateral/bilateral breast reconstructions from healthcare/societal perspectives. PubMed, Embase, Cochrane, Scopus, and CINAHL were searched to derive data from 13,744 patients in 79 prospective studies. Complications requiring surgery (mastectomy necrosis, total/partial flap necrosis, seroma, hematoma, infection, wound dehiscence, abdominal hernia, implant removal/explantation) and revisions (fat necrosis, capsular contracture, asymmetry, scars/redundant tissue, implant rupture/removal, fat grafting) were evaluated over yearly cycles. Reconstructions included: direct-to-implant (DTI), tissue expander-to-implant (TEI), latissimus dorsi flap-to-implant (LDI), latissimus dorsi (LD), pedicled transverse rectus abdominis myocutaneous (TRAM), free TRAM, deep inferior epigastric perforator/superficial inferior epigastric artery (DIEP/SIEA), thigh-based, or gluteal based flaps. Outcomes were incremental cost-effectiveness ratios (ICER) and net monetary benefits (NMB). Willingness-to-pay thresholds were $50,000 and $100,000.

[RESULTS] From a healthcare perspective for unilateral reconstruction, compared to LD, the ICER for DTI was -$42,109.35/quality-adjusted life-years (QALY), LDI was -$25,300.83/QALY, TEI was -$22,036.02/QALY, DIEP/SIEA was $8307.65/QALY, free TRAM was $8677.26/QALY, pedicled TRAM was $13,021.44/QALY, gluteal-based was $17,698.99/QALY, and thigh-based was $23,447.82/QALY. NMB of DIEP/SIEA was $404,523.47, free TRAM was $403,821.40, gluteal-based was $392,478.64, thigh-based was $387,691.70, pedicled TRAM was $376,901.83, LD was $370,646.93, DTI was $339,668.77, LDI was $334,350.30, and TEI was $329,265.84.

[CONCLUSIONS] All nine methods of immediate breast reconstruction were considered cost-effective from healthcare/societal perspectives. LD provided the lowest costs, while DIEP/SIEA provided the greatest effectiveness and NMB.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 7
합병증 necrosis 괴사 dict 2
시술 flap 피판재건술 dict 1
시술 latissimus dorsi flap 피판재건술 dict 1
해부 fat scispacy 1
해부 tissue scispacy 1
해부 TEI → tissue expander-to-implant scispacy 1
합병증 wound scispacy 1
합병증 abdominal scispacy 1
합병증 hematoma 혈종 dict 1
합병증 pedicled transverse scispacy 1
합병증 seroma 장액종 dict 1
합병증 infection 감염 dict 1
합병증 gluteal based scispacy 1
합병증 flap necrosis 괴사 dict 1
합병증 pedicled TRAM scispacy 1
합병증 capsular contracture 피막구축 dict 1
합병증 asymmetry 비대칭 dict 1
합병증 wound dehiscence 상처열개 dict 1
합병증 implant rupture 보형물 파열 dict 1
약물 NMB → net monetary benefits scispacy 1
약물 [BACKGROUND] Women scispacy 1
약물 CINAHL scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 breast cancer C0006142
Malignant neoplasm of breast
scispacy 1
질환 abdominal hernia C0178282
Hernia of abdominal cavity
scispacy 1
질환 TRAM → transverse rectus abdominis myocutaneous C5551436
TRAM Flap Procedure
scispacy 1
질환 inferior epigastric perforator/superficial inferior epigastric artery scispacy 1
기타 women scispacy 1
기타 patients scispacy 1
기타 capsular scispacy 1
기타 latissimus dorsi scispacy 1
기타 epigastric artery scispacy 1
기타 ICER → incremental cost-effectiveness ratios scispacy 1
기타 376,901.83 scispacy 1

MeSH Terms

Breast Neoplasms; Cost-Benefit Analysis; Decision Support Techniques; Female; Humans; Mammaplasty; Mastectomy; Myocutaneous Flap; Necrosis; Postoperative Complications; Prospective Studies; Rectus Abdominis

📑 인용 관계

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문